Last month, USC-supported startup Regenerative Patch Technologies (RPT) was awarded an estimated $12.4 million from the California Institute for Regenerative Medicine (CIRM), a state institute that supports research to address unmet medical needs. This award is the latest round of support for USC researcher Mark Humayun, and represents a milestone for USC researchers whose stem cell patch is under development to treat advanced dry age-related macular degeneration, which can cause blindness. The generous award will go towards testing the safety and efficacy of the patch for treating advanced dry age-related macular degeneration, also known as “geographic atrophy.” 

Read more about this promising patch, its key supporters, and details about the award here